Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

AIM: The aim of this study was to investigate safety of treating diabetic foot ulcers with a topically administered mesenchymal stem cell product. METHOD: Individuals with diabetes, peripheral neuropathy, toe blood pressure > 39 mmHg and non-infected foot ulcers with duration of four to fifty-two...

Descripción completa

Detalles Bibliográficos
Autores principales: Askø Andersen, Jonas, Rasmussen, Anne, Frimodt-Møller, Marie, Engberg, Susanne, Steeneveld, Esther, Kirketerp-Møller, Klaus, O’Brien, Timothy, Rossing, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241309/
https://www.ncbi.nlm.nih.gov/pubmed/35765085
http://dx.doi.org/10.1186/s13287-022-02951-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241309/
https://www.ncbi.nlm.nih.gov/pubmed/35765085
http://dx.doi.org/10.1186/s13287-022-02951-8

Ejemplares similares